Reveragen Biopharma, Inc.

Pioneura Corporation

Jesse Damsker

John Michael McCall

Eric Hoffman

Arthur Glenn Romero

Kanneboyina Nagaraju

Harris A Gelbard

John Mccall

Nagaraju (Raju) Kanneboyina

Provided is an aqueous oral pharmaceutical suspension composition comprising vamorolone Form I. Also provided are methods for its preparation and its use.

Aqueous oral pharmaceutical suspension compositions

The present invention relates to compounds and methods which may be useful as treatments of diseases.

Non-hormonal steroid modulators of NF-&#x3ba;&#x3b2; for treatment of disease

Provided is a tartrate salt of 3-(1H-indol-5-yl)-5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridine and crystalline forms thereof. Also provided are pharmaceutical compositions comprising a tartrate salt disclosed herein and crystalline forms thereof and a pharmaceutically acceptable excipient, and a method of treating a disease or disorder, such as disease or disorder associated with neuroinflammation, comprising administering to a subject in need thereof, a therapeutically effective amount of an acid addition salt disclosed herein or the pharmaceutical composition of the acid addition salt.

Acid addition salts, compositions, and methods of treating

Provided is an acid addition salt of 3-(1H-indol-5-yl)-5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridine selected from a tartrate salt, a phosphate salt, and a fumarate salt. Also provided are pharmaceutical compositions comprising an acid addition salt disclosed herein and a pharmaceutically acceptable excipient, and a method of treating a disease or disorder, such as disease or disorder associated with neuroinflammation, comprising administering to a subject in need thereof, a therapeutically effective amount of an acid addition salt disclosed herein or the pharmaceutical composition of the acid addition salt.

Growing community of inventors

Alexandria, VA, United States of America

Jesse Damsker